1. Home
  2. ATYR vs FSBW Comparison

ATYR vs FSBW Comparison

Compare ATYR & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.78

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

N/A

Current Price

$42.85

Market Cap

305.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ATYR
FSBW
Founded
2005
1936
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
305.6M
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
ATYR
FSBW
Price
$0.78
$42.85
Analyst Decision
Buy
Hold
Analyst Count
6
1
Target Price
$8.75
$44.00
AVG Volume (30 Days)
2.6M
14.6K
Earning Date
11-06-2025
01-20-2026
Dividend Yield
N/A
2.61%
EPS Growth
N/A
N/A
EPS
N/A
4.09
Revenue
$190,000.00
$140,954,000.00
Revenue This Year
N/A
$10.46
Revenue Next Year
$18,728.88
$4.42
P/E Ratio
N/A
$10.50
Revenue Growth
N/A
1.07
52 Week Low
$0.64
$34.61
52 Week High
$7.29
$46.20

Technical Indicators

Market Signals
Indicator
ATYR
FSBW
Relative Strength Index (RSI) 43.35 68.46
Support Level $0.70 $39.48
Resistance Level $0.83 $43.24
Average True Range (ATR) 0.06 0.69
MACD 0.03 0.28
Stochastic Oscillator 57.87 94.68

Price Performance

Historical Comparison
ATYR
FSBW

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: